PING: Pharmaceutical Industry Network Group

The Pharmaceutical Industry Network Group (PING)

PING is a diverse networking group, solely for people who are in the pharmaceutical supply chain with the main aim to discuss and share best practice, ideas and generally help each other in times of great change.

PING has been recognised by the Legal 360 Group with an award for 'Most Innovative Marketing Idea', and continues to strengthen the pharmaceutical sector for its members.

This page includes information regarding: PING logo 203x122

Who attends PING?
Who runs PING?
How much does PING cost?
When and where does PING meet?
Subscribe to our sector law brief

Quick Enquiry

PING Conference Press Releases

Who Attends PING?

Attendees range from across the pharma supply chain, from suppliers to pharmacists, including:

prescription-based suppliers
OTC suppliers
generics suppliers
manufacturers
wholesalers
logistics suppliers
orphan drugs suppliers
named patient suppliers
comparator drug suppliers
specials suppliers
exporters and importers
regulatory advisers
pharma researchers
clinical trial statisticians
market access consultants
pharma data consultants
retail community pharmacy

Who Runs PING?

Paul Gershlick of VWV is Chair of the Group, and is supported by the Watford Chamber of Commerce, Watford Council and Hertfordshire Local Enterprise Partnership. All have the objective of enhancing the sector in the region as a centre of excellence and facilitating the spread of good industry practice.

How Much Does PING Cost?

There is no charge to be a member. Some events have a limited charge to cover costs.

When and Where Does PING Meet?

PING has its centre in Watford within Hertfordshire and people attend from the surrounding areas.

PING has two types of events:

Annual PING Conference

Our annual PING conferences are typically attended by over 100 people from around the country and further afield to hear presentations on hot topics affecting the industry. The gatherings make for useful networking opportunities.

Past topics have included:

The future of pharma, by Professor Brian Smith
Parliament’s answer to the supply shortage crisis, presented by Sir Kevin Barron MP
Who’s who in the new NHS – speakers from pioneering CCGs, HWBs and AHSNs
2020 pharma – from vision to decision, by Jo Pisani and Stephen Aherne at PwC
Medicine adherence – with speakers from Proteus and behavioural specialists, Hamell
Navigating the NHS maze - presentations by NICE, MAP BioPharma Limited and DigitalHealth.London
Implementing the Falsified Medicines Directive - speakers including SecurMed, Roche, BAEPD, BGMA, HDA, NPA
Brexit: What's Next for Pharma - with speakers from MHRA, NSF Pharma Biotech, BAEPD and University of Hertfordshire
Brexit Part 2 - presentations from EMIG, NIHR, BAEPD, NSF Pharma Biotech, NPA, FTI and Dierks + Company
Britain's Great Life Sciences Future - Genomics, Personalised Medicine and AI - speakers from Genomics England, Cell & Gene Therapy Catapult, Deloitte, Benevolent AI, Congenica, Avesthagen
UK Life Sciences in a Changed World - opportunities through innovation and collaboration. Speakers from Pfizer, GSK, University of Oxford, The Office for Life Sciences, NHS England and Improvement, MHRA, IQVIA, HDR UK, Genomics Plc, ICW
The Golden Age for Life Sciences Innovation - Speakers from Government, NICE, NHS England & Improvement, Accelerated Access Collaborative, Our Future Health, BGF, Parkwalk Advisors

PING Roundtable Meetings

Each PING roundtable meeting is typically attended by about 20 people. They come from different parts of the industry, which makes for a great mix and discussions and learning opportunities from different angles. Attendees leave our meetings with greater insight into the sector, new connections, introductions and other opportunities.

PING Innovation Award

The PING Innovation Award recognises individuals and organisations whose innovative ideas, products, services or processes in the Pharmaceuticals and Life Sciences sector are making a positive impact on people's lives.

Previous winners include:

2022 - Achilles Therapeutics
2021 - Stevenage Bioscience Catalyst
2020 - Cell and Gene Therapy Catapult
2019 - Dr Harry Destecroix, CEO and Co-Founder at Unit DX
2018 - Paul Strickland Scanner Centre
2017 - Sigma Pharmaceuticals Plc
2016 - University of Hertfordshire
2015 - Leslie Morgan of Durbin Plc and Proteus Digital Health

Subscribe to Our Sector Law Brief

If you would like to keep abreast of PING as well as legal news in the Pharmaceuticals and Life Sciences sector, please subscribe to our Law Brief.

For more information about the Pharmaceutical Industry Network Group (PING), please contact Paul Gershlick on 01923 919 320.

Get in touch

Are you looking for legal services? Please complete the form below to find out how our specialist lawyers can support you.

First name(*)

Please enter your first name.

Last name(*)

Please enter your last name

Email address(*)

Please enter a valid email address

Telephone(*)

Please enter your telephone number.

I prefer to be contacted by:(*)

Telephone

Invalid Input

How can we help you?(*)

Please limit text to alphanumeric and the following special characters: .,?

Preferred office location:

Should you need to visit an office

See our privacy page to find out how we use and protect your data.

Invalid Input

PING (Pharmaceutical Industry Network Group)

Pharmaceuticals & Life Sciences

Paul Gershlick

Tom Cahill

John Zucker